1. Department
of Clinical Neuroscience, Center for Psychiatry Research, Karolinska Institutet and Stockholm Country Council, SE-171 76 Stockholm, Sweden
2. IntelliSyn Pharma, Montreal H4S 1Z9, Canada
3. PET Science Centre at Karolinska Institutet, Personalised Healthcare and Biomarkers, AstraZeneca R&D, SE-171 76 Stockholm, Sweden